Johnson & Johnson

Product And Operating Company News Archive

Need to know more about a new skin care product? A new surgical device? A new pain relief medication? You can search here for the information you need from a Johnson & Johnson company.

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... 34 Next >

	FDA Issues Complete Response Letter to Janssen Biotech, Inc. for SIMPONI® Supplemental Biologic License Application July 22, 2011
	Telaprevir Receives Positive Opinion From The Committee For Medicinal Products For Human Use (Chmp) For The Treatment Of Genotype-1 Hepatitis C Virus (HCV) July 22, 2011
	Zytiga® Receives Positive Regulatory Recommendation In The European Union For Treatment Of Metastatic Castration Resistant Prostate Cancer July 22, 2011
	Ortho Clinical Diagnostics Launches Vitros® 4600 Chemistry System For Mid- To High-Volume Laboratories July 22, 2011
	Janssen Therapeutics Teams Up With Celebrity Designer David Bromstad To Encourage HIV Testing July 21, 2011
	Edurant™ 96-Week Phase 3 Safety And Efficacy Data Presented At International Aids Society Conference July 19, 2011

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... 34 Next >

Employees

This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2012. All Rights Reserved.